Enhancement of skin permeation of docetaxel: a novel approach combining microneedle and elastic liposomes.
暂无分享,去创建一个
Yuqin Qiu | Yunhua Gao | Yunhua Gao | Y. Qiu | Fang Li | Fang Li | Kejia Hu | Kejia Hu
[1] Mark G. Allen,et al. Lack of pain associated with microfabricated microneedles. , 2001 .
[2] P. Ramarao,et al. In vitro transdermal iontophoretic transport of timolol maleate: effect of age and species. , 2001, Journal of Controlled Release.
[3] A. Schätzlein,et al. Transfersomes-mediated transepidermal delivery improves the regio-specificity and biological activity of corticosteroids in vivo , 1997 .
[4] J. Hadgraft,et al. Influence of phloretin and 6-ketocholestanol on the skin permeation of sodium-fluorescein. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[5] Qiaojun He,et al. Synthesis and evaluation of water-soluble docetaxel prodrugs-docetaxel esters of malic acid. , 2007, Bioorganic & medicinal chemistry.
[6] N. K. Jain,et al. Elastic liposomes mediated transdermal delivery of an anti-hypertensive agent: propranolol hydrochloride. , 2007, Journal of pharmaceutical sciences.
[7] M. Allen,et al. Microfabricated microneedles: a novel approach to transdermal drug delivery. , 1998, Journal of pharmaceutical sciences.
[8] G. Cevc,et al. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. , 1992, Biochimica et biophysica acta.
[9] G. E. El Maghraby,et al. Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration. , 2000, International journal of pharmaceutics.
[10] D. Barrow,et al. Microfabricated silicon microneedles for nonviral cutaneous gene delivery , 2004, The British journal of dermatology.
[11] B. Godin,et al. Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[12] E. Touitou,et al. Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. , 2000, Biomaterials.
[13] N. K. Jain,et al. Proultraflexible lipid vesicles for effective transdermal delivery of levonorgestrel: Development, characterization, and performance evaluation , 2005, AAPS PharmSciTech.
[14] M. Mezei,et al. Liposomes—A selective drug delivery system for the topical route of administration: gel dosage form , 1982, The Journal of pharmacy and pharmacology.
[15] B. Godin,et al. Mechanism of bacitracin permeation enhancement through the skin and cellular membranes from an ethosomal carrier. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[16] Adrian C. Williams,et al. Skin hydration and possible shunt route penetration in controlled estradiol delivery from ultradeformable and standard liposomes , 2001, The Journal of pharmacy and pharmacology.
[17] M. Foldvari,et al. Dermal drug delivery by liposome encapsulation: clinical and electron microscopic studies. , 1990, Journal of microencapsulation.
[18] M. Mezei,et al. Topical Anesthesia of the Skin by Liposome‐Encapsulated Tetracaine , 1988, Anesthesia and analgesia.
[19] O. Abdallah,et al. Lipid vesicles for skin delivery of drugs: reviewing three decades of research. , 2007, International journal of pharmaceutics.
[20] J. Bouwstra,et al. Vesicles as a tool for transdermal and dermal delivery. , 2005, Drug discovery today. Technologies.
[21] P. Agache,et al. Effect of occlusion on in vitro percutaneous absorption of two compounds with different physicochemical properties. , 1992, Skin pharmacology : the official journal of the Skin Pharmacology Society.
[22] K. Sugibayashi,et al. Species differences in percutaneous absorption of nicorandil. , 1991, Journal of pharmaceutical sciences.
[23] M. Mezei,et al. Liposomes--a selective drug delivery system for the topical route of administration. Lotion dosage form. , 1980, Life sciences.
[24] R. Marks,et al. The occlusive effects of protective gloves on the barrier properties of the stratum corneum. , 1993, Current problems in dermatology.
[25] Wijaya Martanto,et al. Transdermal Delivery of Insulin Using Microneedles in Vivo , 2004, Pharmaceutical Research.
[26] Mark R Prausnitz,et al. Microneedles for transdermal drug delivery. , 2004, Advanced drug delivery reviews.
[27] K. Sugibayashi,et al. Effects of pretreatment of needle puncture and sandpaper abrasion on the in vitro skin permeation of fluorescein isothiocyanate (FITC)-dextran. , 2006, International journal of pharmaceutics.
[28] F. Dosio,et al. Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxel. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[29] C. van Nostrum,et al. The effect of core composition in biodegradable oligomeric micelles as taxane formulations. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[30] A. Billich,et al. Comparison of human skin or epidermis models with human and animal skin in in-vitro percutaneous absorption. , 2001, International journal of pharmaceutics.
[31] Regina Luttge,et al. Silicon micromachined hollow microneedles for transdermal liquid transport , 2003 .
[32] Amit Jain,et al. Effect of lipid bilayer alteration on transdermal delivery of a high-molecular-weight and lipophilic drug: studies with paclitaxel. , 2004, Journal of pharmaceutical sciences.
[33] Diane E. Sutter,et al. Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery , 2002, Nature Medicine.
[34] Dorian Liepmann,et al. Clinical microneedle injection of methyl nicotinate: stratum corneum penetration , 2005, Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging.
[35] R. Guy,et al. Bioavailability of topically administered steroids: a "mass balance" technique. , 1988, The Journal of investigative dermatology.
[36] M. Riley,et al. Comparative topical anaesthesia of EMLA and liposome-encapsulated tetracaine , 1997, Canadian journal of anaesthesia = Journal canadien d'anesthesie.
[37] M. Foldvari. In Vitro Cutaneous and Percutaneous Delivery and in Vivo Efficacy of Tetracaine from Liposomal and Conventional Vehicles , 1994, Pharmaceutical Research.
[38] J. Schellens,et al. Progress in the Development of Alternative Pharmaceutical Formulations of Taxanes , 2001, Investigational New Drugs.
[39] Jung-Hwan Park,et al. Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[40] T M Morgan,et al. Transdermal penetration enhancers: applications, limitations, and potential. , 1999, Journal of pharmaceutical sciences.
[41] Mark G. Allen,et al. Hollow metal microneedles for insulin delivery to diabetic rats , 2005, IEEE Transactions on Biomedical Engineering.
[42] Mark G. Allen,et al. Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: Fabrication methods and transport studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.